Skip to main content
Pixium Vision logo

Pixium Vision — Investor Relations & Filings

Ticker · ALPIX ISIN · FR001400JX97 LEI · 96950046OPLRLKKEOO08 PA Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2021-07-13 Share Issue/Capital Cha…
Country FR France
Listing PA ALPIX

About Pixium Vision

https://www.pixium-vision.com/

Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.

Recent filings

Filing Released Lang Actions
Pixium Vision annonce une augmentation de capital d’environ 8 millions € par placement privé
Share Issue/Capital Change Classification · 99% confidence The document is a press release from Pixium Vision dated July 13, 2021, announcing a capital increase of approximately €8 million through a private placement involving the subscription of new shares and warrants (ABSA). This action directly relates to the company raising funds and changing its capital structure. According to the definitions, 'Capital/Financing Update' (Code: CAP) is the most appropriate category for announcements concerning company fundraising or capital structure changes. The document details the terms of the issuance, the use of proceeds, and the resulting shareholder structure, confirming it is a primary announcement of a financing event, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2021-07-13 French
Pixium Vision announces a capital increase of approximately €8 million through a private placement
Capital/Financing Update Classification · 99% confidence The document is titled "Pixium Vision announces a capital increase of approximately €8 million through a private placement" and details the subscription of new shares and warrants (ABSA). This clearly indicates a fundraising or financing activity involving the issuance of new securities. This aligns directly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). Since it is the announcement detailing the terms of the capital raise itself, it is classified as CAP, not RPA or RNS.
2021-07-13 English
Pixium Vision annonce une suspension de cours
Delisting Announcement Classification · 99% confidence The document is a very short announcement (2779 characters) dated July 13, 2021, stating that Pixium Vision has requested a trading suspension ('suspension de la cotation') on Euronext Paris pending the publication of a new communication. This is a specific, immediate corporate action announcement that is not a full financial report (like 10-K or IR), an earnings release (ER), or a dividend notice (DIV). It is a regulatory/market-sensitive announcement that doesn't fit the specific categories like DIRS, MANG, or TAR. Given its nature as an immediate, non-standard market event announcement, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements not covered elsewhere.
2021-07-13 French
RAPPORT ANNUEL 2020
Annual Report Classification · 100% confidence The document is explicitly titled 'RAPPORT ANNUEL 2020' (Annual Report 2020) and includes a comprehensive table of contents covering management reports, consolidated financial statements under IFRS, audit reports, and corporate governance information for the fiscal year ending December 31, 2020. It is a full-length annual report, not an announcement or a summary. FY 2020
2021-07-01 French
Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte du 27 mai 2021
Transaction in Own Shares Classification · 99% confidence The document is titled "Communiqué information réglementée" and explicitly describes the objectives and modalities of a share repurchase program ("programme de rachat d'actions") authorized by the Mixed General Meeting on May 27, 2021. It details the maximum funds, maximum number of shares, maximum purchase price, and duration related to buying back the company's own shares. This content directly corresponds to the definition of a Transaction in Own Shares (Share Repurchase/Issuance). The code for this is POS.
2021-05-27 French
Communiqué sur la composition du bureau de l’Assemblée Générale Mixte du 27 mai 2021
AGM Information Classification · 98% confidence The document is titled "Communiqué sur la composition du bureau de l'Assemblée Générale Mixte du 27 mai 2021" (Communiqué on the composition of the bureau of the Combined General Meeting of May 27, 2021). It details who will preside, act as scrutineers, and serve as secretary for the upcoming General Meeting. This content directly relates to the organization and procedures of the Annual General Meeting (AGM). Although it is a communiqué, its specific subject matter points directly to AGM procedures rather than being a general regulatory announcement (RNS) or a proxy solicitation document (PSI). Therefore, the most appropriate classification is AGM Information (AGM-R). The document length (4927 chars) is substantial enough that it is not merely an announcement of an attachment, but the substantive content itself regarding the AGM setup.
2021-05-26 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.